Stacey R. Lindsley

SAR of tertiary carbinamine derived BACE1 inhibitors: role of aspartate ligand amine pKa in enzyme inhibition.

Adam J. Simon, Georgia B. McGaughey, Philippe G. Nantermet, 2010, Bioorganic & medicinal chemistry letters.

Comparison of Topological, Shape, and Docking Methods in Virtual Screening.

Robert P. Sheridan, Christopher I. Bayly, Vladimir N. Maiorov, 2007 .

Imidazole acetic acid TAFIa inhibitors: SAR studies centered around the basic P(1)(') group.

J. Barrow, J. Vacca, D. Colussi, 2004, Bioorganic & medicinal chemistry letters.

Design, synthesis, and SAR of macrocyclic tertiary carbinamine BACE-1 inhibitors.

D. Hazuda, A. Simon, G. McGaughey, 2007, Bioorganic & medicinal chemistry letters.

Discovery, synthesis, and structure-activity relationship development of a series of N-4-(2,5-dioxopyrrolidin-1-yl)phenylpicolinamides (VU0400195, ML182): characterization of a novel positive allosteric modulator of the metabotropic glutamate receptor 4 (mGlu(4)) with oral efficacy in an antiparkins

Anna L. Blobaum, Y. Smith, S. Jadhav, 2011, Journal of medicinal chemistry.

Discovery, Synthesis, SAR Development of a Series of N -4-(2,5-dioxopyrrolidin-1-yl)-phenylpicolinamides (VU0400195, ML182): Characterization of a Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 (mGlu 4 ) with Oral Efficacy in an anti-Parkinsonian Animal Model

Colleen, Y. Smith, C. Lindsley, 2011 .

3-Cyano-5-fluoro-N-arylbenzamides as negative allosteric modulators of mGlu(5): Identification of easily prepared tool compounds with CNS exposure in rats.

Andrew S. Felts, S. Jadhav, C. Lindsley, 2010, Bioorganic & medicinal chemistry letters.

Discovery and SAR of novel mGluR5 non-competitive antagonists not based on an MPEP chemotype.

C. Lindsley, P. Conn, Stacey Lindsley, 2009, Bioorganic & medicinal chemistry letters.

Comparison of Topological, Shape, and Docking Methods in Virtual Screening

Robert P. Sheridan, Christopher I. Bayly, Vladimir N. Maiorov, 2007, J. Chem. Inf. Model..